Clinical updates, including trial initiations, enrollment status and data readouts and publications: Altapure, Biodesix, Biotronik, Clinical Genomics, Procept Biorobotics, Roche.

Med-tech firms raising money in public or private financings, including: 1Life Healthcare, Inari Medical, Magnolia Medical Technologies, Siren, Stryker, Wright Medical.

New hires and promotions in the med-tech industry, including: Axim Biotechnologies, Centricity Vision, Flagship Biosciences, Neuromod Devices, RTI Surgical Holdings.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Algernon, Amivas, Anivive, Astellas, Azitra, Beyond Air, BMS, Diffusion, Fresenius Kabi, GSK, Immunitybio, Intelgenx, Microbion, Protara, Radius, Regenerx, Regeneron, Relmada, Sanofi, Sorrento.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Adamis, Aileron, Alucent, Auris, Biolinerx, Compugen, Cytovation, Genentech, GT, Ironwood, Macrogenics, Mersana, Mina, Nascent, Novartis, NS Pharma, Radius, Transcenta, Vir, Zynerba.

Biopharmas raising money in public or private financings, including: Argenx, Atara, Abcellera, Caladrius, Deerfield, Fortress, Great Lakes Discoveries, Hoth, Outlook, Pliant, Pneumagen, Saniona, Seneca, Turning Point, Vaxcyte, VBI Vaccines.

New hires and promotions in the biopharma industry, including: Amunix, Arcus, Assembly, Brainstorm Cell, Corbus, Evox, Kinnate, Matrisys, TCR², Urovant.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbott Laboratories, Biotricity, Capsule Technologies, EKF Diagnostics, Indica Labs, Kings College London, Longhorn Vaccines and Diagnostics, Medisana, Meditemi, Octo, Oncimmune Holdings, Open Pathology, Opencell, Opentrons, Orthogenrx, Sherlock Biosciences, Sinai Health System, Somatix, Sunquest Information Systems, Temi, Transenterix, Varian, Vayyar.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Antisense, Arch Biopartners, Covis, Daiichi Sankyo, Diffusion, Incyte, Mezzion.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Anavex Life Sciences, Appili, Astellas, Astrazeneca, Atea, Beigene, Calcimedica, Daiichi Sankyo, Fibrogen, Genexine, I-Mab Biopharma, Octapharma USA, Organicell Regenerative Medicine.